These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neonatal screening for phenylketonuria and hypothyroidism in France. A 12-year experience]. Briard ML Ann Biol Clin (Paris); 1988; 46(6):387-92. PubMed ID: 3177978 [TBL] [Abstract][Full Text] [Related]
3. State screening for metabolic disorders in newborns. Stevens MB; Rigilano JC; Wilson CC Am Fam Physician; 1988 Apr; 37(4):223-8. PubMed ID: 3358346 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening]. Durand-Zaleski I; Bastuji-Garin S Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104 [No Abstract] [Full Text] [Related]
5. Diagnosis and treatment: interpreting the positive screening test in the newborn infant. Scriver CR Pediatrics; 1967 May; 39(5):764-8. PubMed ID: 6026878 [No Abstract] [Full Text] [Related]
6. Galactosaemia--a controversial disorder. Screening & outcome. Ireland 1972-1992. Badawi N; Cahalane SF; McDonald M; Mulhair P; Begi B; O'Donohue A; Naughten E Ir Med J; 1996; 89(1):16-7. PubMed ID: 8984074 [TBL] [Abstract][Full Text] [Related]
7. [Phenylketonuria in spite of screening]. Maaswinkel-Mooij PD; Kist-van Holthe tot Echten JE; Maat-Kievit JA Ned Tijdschr Geneeskd; 1993 Aug; 137(34):1727-9. PubMed ID: 7690466 [TBL] [Abstract][Full Text] [Related]
8. Newborn metabolic screening in Minnesota. II. PKU and galactosemia. Jenkins MB Minn Med; 1981 Jul; 64(7):429-32, 398. PubMed ID: 7266450 [No Abstract] [Full Text] [Related]
9. Neonatal birth parameters of positive newborns at PKU screening as predictors of false-positive and positive results at recall-testing. Zaffanello M; Zamboni G; Maffeis C; Tatò L J Med Screen; 2003; 10(4):181-3. PubMed ID: 14738655 [TBL] [Abstract][Full Text] [Related]
10. [Anti-alpha-gliadin antibodies. Sensitivity, specificity and correlation with blood xylose test in the 3 diagnostic stages of celiac disease in children]. Ventura A; Florean P; Trevisan M; Not T; Perticarari S; Quadrifoglio F; Torre G; Cauci S Pediatr Med Chir; 1987; 9(6):653-60. PubMed ID: 3444740 [TBL] [Abstract][Full Text] [Related]
11. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541 [TBL] [Abstract][Full Text] [Related]
12. [Screening for congenital metabolic disorders. Indication and results]. Bickel H Monatsschr Kinderheilkd; 1983 Jun; 131(6):323-7. PubMed ID: 6888386 [No Abstract] [Full Text] [Related]
13. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns. Boemer F; Vanbellinghen JF; Bours V; Schoos R J Med Screen; 2006; 13(3):132-6. PubMed ID: 17007654 [TBL] [Abstract][Full Text] [Related]
14. [Sickle cell disease in heel injection screening. I]. Peters M; Appel IM; Cnossen MH; Breuning-Boers JM; Heijboer H Ned Tijdschr Geneeskd; 2009 May; 153(18):854-7. PubMed ID: 19475863 [No Abstract] [Full Text] [Related]
15. Ethnic and gender patterns for the five congenital disorders in Texas from 1992 through 1998. Strahan JE; Canfield MA; Drummond-Borg LM; Neill SU Tex Med; 2002 Sep; 98(9):80-6. PubMed ID: 12271912 [TBL] [Abstract][Full Text] [Related]
16. [Reliability of the tuberculin scarification test in the systematic search for tuberculous contamination in school populations (author's transl)]. Jeurissen A Acta Tuberc Pneumol Belg; 1974; 64(5):413-82. PubMed ID: 4209975 [No Abstract] [Full Text] [Related]